Cigna releases transcript of Q2 2026 earnings call

Cigna Corporation posted a transcript of its Q2 2026 earnings call attended by CEO Brian Evanko, CFO Ann Dennison, and IR head Ralph Giacobbe.

• Q2 results: revenue of $71.7 billion, adjusted EPS of $7.78; 2026 adjusted EPS outlook raised to at least $30.45.
• Evernorth: revenue of $61.5 billion, pre-tax adjusted earnings of $1.7 billion; Specialty and Care earnings rose 22% to $1.1 billion.
• Pharmacy Benefit Services pre-tax adjusted earnings of $609 million; Signature rebate-free model to enter Cigna Healthcare fully insured plans in 2027, with broader launch in 2028.
• Cigna Healthcare: revenue of $11.8 billion, pre-tax adjusted earnings of $1.3 billion; medical care ratio of 84.5%, with high single-digit trends described as elevated but stable.